MedTrace Logo

Combined PENG and LFCN Block for Total Hip Arthroplasty

NCT04996290 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-08-09

No results posted yet for this study

Summary

A clinical trial investigating the effect of a combined locoregional anesthesia technique on the postoperative analgesia outcomes after a total hip arthroplasty. A PENG block will be used in combination with a LFCN block. The results will be compared to a control group that is solely treated with intravenous analgesia. This technique aims to provide improved pain scores after surgery without interference of revalidation.

Conditions

  • Anesthesia, Conduction
  • Pain, Postoperative
  • Arthroplasty, Replacement, Hip

Interventions

PROCEDURE

PENG + LFCN block

Regional anesthesia technique

DRUG

Ropivacaine injection

Local anesthetic used for peripheral nerve block.

Sponsors & Collaborators

  • University Hospital, Antwerp

    lead OTHER

Principal Investigators

  • Yzabel Vandevivere, MD · AZ Monica

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-09-30
Completion
2020-10-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04996290 on ClinicalTrials.gov